Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Denver PWM LLC

Denver PWM LLC cut its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 10.6% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 370 shares of the biotechnology company’s stock after selling 44 shares during the quarter. Denver PWM LLC’s holdings in Axon Enterprise were worth $220,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of AXON. Asset Dedication LLC raised its holdings in shares of Axon Enterprise by 11.3% in the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock worth $106,000 after acquiring an additional 18 shares during the last quarter. Bleakley Financial Group LLC raised its holdings in shares of Axon Enterprise by 1.3% in the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock worth $908,000 after acquiring an additional 20 shares during the last quarter. Venturi Wealth Management LLC raised its holdings in shares of Axon Enterprise by 2.7% in the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock worth $477,000 after acquiring an additional 21 shares during the last quarter. Insigneo Advisory Services LLC raised its holdings in shares of Axon Enterprise by 1.4% in the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock worth $627,000 after acquiring an additional 22 shares during the last quarter. Finally, Menard Financial Group LLC raised its holdings in shares of Axon Enterprise by 0.8% in the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock worth $1,204,000 after acquiring an additional 24 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Stock Performance

Axon Enterprise stock opened at $513.22 on Friday. The stock’s 50-day moving average is $619.94 and its 200-day moving average is $518.66. The company has a market cap of $39.13 billion, a price-to-earnings ratio of 132.62, a price-to-earnings-growth ratio of 5.43 and a beta of 1.05. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a 12 month low of $265.32 and a 12 month high of $715.99.

Insider Transactions at Axon Enterprise

In other news, President Joshua Isner sold 1,291 shares of the stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price of $642.43, for a total value of $829,377.13. Following the completion of the sale, the president now owns 181,892 shares in the company, valued at approximately $116,852,877.56. This trade represents a 0.70 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 8,711 shares of company stock worth $5,631,561 in the last three months. 6.10% of the stock is currently owned by company insiders.

Analyst Ratings Changes

AXON has been the subject of a number of analyst reports. Northcoast Research cut Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday. The Goldman Sachs Group upped their target price on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 target price on the stock. in a research report on Thursday. Finally, TD Cowen assumed coverage on Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price on the stock. Three investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $561.31.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.